Contrast Agents & Injectors

Showing all 4 results

X-Ray, Mammography and Contrast Agents Market Report Suite | United States | 2010-2016 | MedSuite

In 2009, the U.S. market for X-ray, mammography and contrast agents was valued at over $5 billion. The medical imaging equipment market includes X-rays, mammography as well as contrast agents and injectors. The market declined in 2009 due to the deficit reduction act, which limited reimbursement for some imaging modalities. In addition, the global economic recession of 2008 to 2009 negatively impacted the market; however, the market is expected to recover beginning in 2010.


Medical Imaging Market Analysis, Size, Trends | United States | 2016-2022 | MedSuite

Medical imaging is the technique and process by which images of the human body are created for clinical uses. Types of medical imaging include radiography, nuclear medicine, magnetic resonance, endoscopy, thermography, sonography and photography. Other methods that do not produce images are also considered to be a part of medical imaging, as they provide diagnostic data such as electroencephalography, magnetencephalography and electrocardiography. Prior to the use of medical imaging, physiological issues were investigated through surgery, which posed a much higher risk to the patient. This U.S. medical imaging equipment market includes: X-rays, mammography, magnetic resonance imaging (MRI), computed tomography (CT), nuclear medicine, ultrasound imaging systems as well as contrast agents and injectors.


Contrast Agents and Injectors Market Analysis | United States | 2016-2022 | MedCore

The U.S. market for contrast agents and injectors includes X-ray and CT agents, MRI agents and ultrasound agents as well as contrast injectors. In 2015, MRI contrast agents represented the largest segment in the contrast agent and injector market. This segment will continue to have the highest market value driven by increasing procedural volumes.


Medical Imaging Devices Procedure Volume Analysis | United States | 2016-2022 | MedPro

The following report is a summary of the major procedural codes that were investigated and analyzed for consideration in the generation of procedural and market estimates and forecasts in this report. The number of procedures reported in this report is built from a bottom-up technique by investigating the number procedural claims at an outpatient and inpatient level. Procedural claims for a total of 568 CPT codes and 101 ICD-9-CM vol.3 codes were investigated and considered as part of this analysis.